bpc-157 arginate bioavailability Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing BPC-157 Dosage Protocol: Injection Guide
Description
Randomization: AOD-9604 at doses 0.25, 0.5, 1.0 mg daily SC vs placebo
As most of them are currently in experimental stages, we highlight the need for clinical trials and additional research to confirm their feasibility
The answer depends on your individual needs and goals
We usually see some improvement in the first few weeks, with more noticeable changes later
Most users do well with 6mm needles, which penetrate deep enough to reach subcutaneous fat but not so deep as to risk intramuscular injection in typical sites
To understand how these substances may affect the body, well need rigorous clinical trials studying individual peptides, experts say
